Article Text
Abstract
A “cocaine vaccine” is a promising immunotherapeutic approach to treating cocaine dependence which induces the immune system to form antibodies that prevent cocaine from crossing the blood brain barrier to act on receptor sites in the brain. Studies in rats show that cocaine antibodies block cocaine from reaching the brain and prevent the reinstatement of cocaine self administration. A successful phase 1 trial of a human cocaine vaccine has been reported. The most promising application of a cocaine vaccine is to prevent relapse to dependence in abstinent users who voluntarily enter treatment. Any use of a vaccine to treat cocaine addicts under legal coercion raises major ethical issues. If this is done at all, it should be carefully trialled first, and only after considerable clinical experience has been obtained in using the vaccine to treat voluntary patients. There will need to be an informed community debate about what role, if any, a cocaine vaccine may have as a way of preventing cocaine addiction in children and adolescents.
- cocaine
- vaccine
- drug dependence
- treatment
- ethics
- public policy
Statistics from Altmetric.com
Footnotes
Linked Articles
- Symposium on drugs
Read the full text or download the PDF:
Other content recommended for you
- Further ethical and social issues in using a cocaine vaccine: response to Hall and Carter
- Cocaine and the heart
- Genetic risk factors influenced cocaine abuse and dependence more than cocaine use in women
- A research agenda for assessing the potential contribution of genomic medicine to tobacco control
- Global disparities in public health guidance for the use of COVID-19 vaccines in pregnancy
- Central and autonomic system signs with in utero drug exposure
- Self-reported cocaine use, emergency physician testing and outcomes in suspected acute coronary syndromes: a nested matched case–control study
- Prenatal drug exposure and maternal and infant feeding behaviour
- Vaccination against tuberculosis in badgers and cattle: an overview of the challenges, developments and current research priorities in Great Britain
- Silent myocardial damage in cocaine addicts